Infonavit Announces its Financial Plan

Size: px
Start display at page:

Download "Infonavit Announces its Financial Plan"

Transcription

1 Latin American Equity Research Mexico City, November 28, 2007 Sector Report Mexico Cement & Construction HOUSING REVIEW NOVEMBER 2007 Infonavit Announces its Financial Plan Gonzalo Fernández* Vivian Salomón* Mexico: Banco Santander S.A. Mexico: Banco Santander S.A. (5255) (5255) (News/Analysis): At its annual board meeting held on November 28, 2007, Infonavit announced its financial plan for the period, which targets financing between 2. million and 3.57 million mortgage loans during this five-year or a CAGR of 9% and 13%, respectively, for the two sets of projections: the base-case and the potential scenarios, in terms of the amount of financing; below our current estimate for a 16% five-year CAGR. The program announced on November 28 is less aggressive in terms of the number of mortgages compared with the program announced in late 2006 considering a CAGR of between 5% and 10% in the number of mortgages compared with 17% - 20% in the previous scenario. On the positive side, the new program increases the average amount of the mortgages by 33% in We estimate that Infonavit will provide close to 500,000 mortgages in 2007, in line with Infonavit s base-case scenario, but below the more optimistic potential scenario of 540,000 mortgages. We do not believe that during 2007, Infonavit failed to reach its best-case scenario because of lack of demand for mortgages or because of problems in the issuance of mortgage-backed securities, which, in fact, reached expectations, despite more difficult conditions in the financial markets. In our opinion, production levels of houses from homebuilders did not keep pace with the growth in mortgages particularly due to difficult weather conditions (as was the case with Geo), difficulty in getting permits (Ara) and because of the need to adapt production to lower-priced homes, where mortgage availability is higher. We would highlight that neither Sare nor Homex faced difficulties reaching their yearly guidance. Net/Net: In our opinion,n a more conservative program for Infonavit, the largest mortgage institution in Mexico is negative news for the sector because of the less aggressive growth targets compared with the program announced in late This could imply that some companies will issue more conservative growth guidance. We do not believe that this will necessarily result in an overall slowdown in the sector because total units sold 2007E of public homebuilders under coverage represents only 23% of Infonavit mortgages and they rely on other sources of financing. Thus, in our opinion, there is plenty of room to gain market share. The companies with most exposure to Infonavit are Homex with 77% of units sold Jan Sep 2007 and Geo with 55%. While the company with the lowest exposure is Ara with 41% followed by Sare (46%).In our opinion Sare, and Homex could continue growing above the average of the sector, while there is the risk that Geo and Ara could grow at a rate closer to Infonavit s new targets. The increase in the average amount of the loans is a positive, in our opinion because homebuilders were having problems supplying product in the lowest-priced segments of Inofnavit. Universe of Coverage (U.S. Dollars in Millions*) Price Target Upside/ Net Earnings P/E FV/EBITDA Mkt. Company Ticker Rec. 27-Nov Price Down 2007E 2008E 2009E 2007E 2008E 2009E 2007E 2008E 2009E Cap Ara* ARA* Hold % ,324 Geo GEOB Hold % ,699 Homex HXM Buy % ,820 Sare SARE Buy % Urbi URBI* Res Res. Res. Res. Res. Res. Res. Res. Res. Res. Res. Res. 2,941 a Except per share/adr amounts. *. All target prices are for YE2008. Sources: Company reports and Santander Investment estimates. Important disclosures/certifications are in the Important Disclosures section of this report. U.S. investors inquiries should be directed to Santander Investment Securities Inc. at (212) / (212) * Employed by a non-us affiliate of Santander Investment Securities Inc. and is not registered/qualified as a research analyst under NASD rules.

2 Infonavit Announces its Financial Plan The scenario released on November 28 provides a more conservative growth outlook in the number of mortgages. The base-case scenario includes 500,000 homes in 2008, flat with 2007, and 540,000 on the potential scenario, with a modest 8% growth. Furthermore, the five-year scenario targets reaching between 600,000 and 740,000 mortgages in 2010, down from 800,000 and one million loans, respectively. This implies an average CAGR of 10% compared to 20% in the previous plan. The new program plans to reach between 625,000 and 815,000 mortgages in 2011 and a similar number in The difference between the base and potential scenarios is a more aggressive issuance of mortgage-backed securities for Infonavit and more investment from commercial banks in co-financing products. Infonavit targets increasing the percentage of mortgages for homeowners earning less than four minimum salaries from 62% in 2008 to 71.5% in the base-case scenario and 76.1% in the potential scenario, maintaining its focus on the lowest-priced segments of the population. The potential scenario provides for issuing M$20 billion in mortgage-backed securities in 2008 and plans to reach M$58 billion in On the positive side, despite more modest growth in the number of mortgages, Infonavit plans to increase the average amount of the loans from M$239,000 in 2007 to M$319,000 in 2008 or a 33% increase. Total resources in the credit program would increase at a CAGR of 9% and 13%, respectively over Over this five-year period, Infonavit plans to invest between M$982 million and M$1.13 billion including resources from commercial banks in cofinancing programs. The growth in financial resources is also lower than our expectations for a 16% CAGR over the same period and the base for our estimated growth for Mexican homebuilders. Figure 1. Infonavit Financial Plan (Billion Mexican Pesos) 2008E 2009E 2010E 2011E 2012E CAGR 07-12E Base Scenario % Growth 12% 12% 7% 4% % of loans below 4 MW 62.0% 69.6% 70.5% 71.5% 71.5% Potential Scenario % Growth 21% 12% 15% 4% % of loans below 4 MW 64.0% 73.2% 76.1% 76.1% 76.1% Average % Growth 17% 12% 11% 4% MW = minimum wage. Sources: Infonavit and Santander Investment estimates. Figure 2. Infonavit Financial Plan (Thousands of mortgages) E 2008E 2009E 2010E 2011E 2012E CAGR 06-10E Base Scenario % Growth 19% 0% 10% 9% 4% 0% Potential Scenario % Growth 19% 8% 22% 12% 10% 0% Average % Growth 19% 4% 16% 11% 7% 0% Change vs. Previous Scenario * -4% -17% -19% -26% NA NA * Average vs. Average. Sources: Infonavit and Santander Investment estimates for NA Not Available. Figure 3. Mexican Homebuilders Exposure to Infonavit (Units Sold Jan-Sep 2007) Ara Geo Homex Urbi Sare Total Sales 16,6 30,541 35,279 Res 8,956 Infonavit 6,911 16,798 27,304 14,176 4, Infonavit/Total 40.9% 55.0% 77.4% 56.0% 46.0% Sources: Company reports and Santander Investment estimates. 2 Important disclosures/certifications are in the Important Disclosures section of this report. U.S. investors inquiries should be directed to Santander Investment Securities Inc. at (212)

3 IMPORTANT DISCLOSURES Ara 12-Month Relative Performance (U.S. Dollars) ARA Ara Three-Year Stock Performance (U.S. Dollars) H $3.15 9/27/04 B $3.60 3/16/05 B $ /17/05 B $ /27/05 H $4.65 2/2/06 B $4. 3/16/06 B $ /20/06 B $7.55 2/01/07 B $1.85 9/17/ B $ /5/05 3,400 2,0 2,400 1,0 1, Ara (L Axis) Source: Santander Investment. Important disclosures/certifications are in the Important Disclosures section of this report. U.S. investors inquiries should be directed to Santander Investment Securities Inc. at (212) / (212)

4 Infonavit Announces its Financial Plan IMPORTANT DISCLOSURES (CONTINUED) Geo 12-Month Relative Performance (U.S. Dollars) 150 GEO Geo Three-Year Stock Performance (U.S. Dollars) SB $ /7/04 SB $2.35 1/5/05 SB $2.70 2/23/05 SB $ /19/05 SB $3. 2/6/06 SB $ /27/05 H $ /25/06 H $4.30 8/3/06 B $6.00 2/1/07 B $7.00 9/17/ SB $3.00 B $5.80 7/29/05 9/27/ ,500 3,000 2,500 2,000 1,500 1, Geo (L Axis) 4 Important disclosures/certifications are in the Important Disclosures section of this report. U.S. investors inquiries should be directed to Santander Investment Securities Inc. at (212)

5 Homex 12-Month Relative Performance (U.S. Dollars) HOMEX 80 Homex Three-Year Stock Performance (U.S. Dollars) *Initiation of Coverage H$ /2/07 3,500 3, H$ /21/06* H$ /23/07 2,500 2, B$ /4/06 H$ /17/07 1,500 1, HOMEX (L Axis) 500 Important disclosures/certifications are in the Important Disclosures section of this report. U.S. investors inquiries should be directed to Santander Investment Securities Inc. at (212) / (212)

6 Infonavit Announces its Financial Plan Sare 12-Month Relative Performance (U.S. Dollars) SARE Sare Three-Year Stock Performance (U.S. Dollars) B $4.65 1/5/05 B $5.50 4/28/05 SB $ /27/05 B $1. 4/27/07 3,500 3,000 2,500 2,000 1, B $15.00 H $15.50 B $2.20 2/1/06 10/30/06 9/17/ *Initiation of Coverage 1, Sare (L Axis) Source: Santander Investment. 6 Important disclosures/certifications are in the Important Disclosures section of this report. U.S. investors inquiries should be directed to Santander Investment Securities Inc. at (212)

7 Key to Investment Codes IMPORTANT DISCLOSURES Rating Definition % of Companies Covered with This Rating % of Companies Provided Investment Banking Services in the Past 12 Months Buy Expected to outperform the local market benchmark by more than 5.0% % 78.95% Hold Expected to perform within a range of 5.0% above or below the local market benchmark % 21.05% Underperform/Sell Expected to underperform the local market benchmark by more than 5.0%. 8.86% The numbers above reflect our Latin American universe as of Thursday, November 15, For a discussion, if applicable, of the valuation methods used to determine the price targets included in this report and the risks to achieving these targets, please refer to the latest published research on these stocks. Research is available through your sales representative and other electronic systems. Target prices are 2007 year-end unless otherwise specified. Recommendations are based on a total return basis (expected share price appreciation + prospective dividend yield) unless otherwise specified. Stock price charts and rating histories for companies discussed in this report are also available by written request to Santander Investment Securities Inc., 45 East 53 rd Street, 17 th Floor (Attn: Research Disclosures), New York, NY 22 USA. Ratings are established when the firm sets a target price and/or when maintaining or reiterating the rating. Ratings may not coincide with the above methodology due to price volatility. Management reserves the right to maintain or to modify ratings on any specific stock and will disclose this in the report when it occurs. Valuation methodologies vary from stock to stock, analyst to analyst, and country to country. Any investment in Latin American equities is, by its nature, risky. A full discussion of valuation methodology and risks related to achieving the target price of the subject security is included in the body of this report. The benchmark used for local market performance is the country risk of each country plus the 1-year U.S. Treasury yield plus 5.5% of equity risk premium, unless otherwise specified. The benchmark plus or minus the 5.0% differential used to determine the rating is time adjusted to make it comparable with the total return of the stock over the same period. For additional information about our rating methodology, please call (212) This report has been prepared by Santander Investment Securities Inc. ( SIS ) (a subsidiary of Santander Investment I S.A which is wholly owned by Banco Santander, S.A. ("Santander"), on behalf of itself and its affiliates (collectively, Grupo Santander) and is provided for information purposes only. This document must not be considered as an offer to sell or a solicitation of an offer to buy any relevant securities (i.e., securities mentioned herein or of the same issuer and/or options, warrants, or rights with respect to or interests in any such securities). Any decision by the recipient to buy or to sell should be based on publicly available information on the related security and, where appropriate, should take into account the content of the related prospectus filed with and available from the entity governing the related market and the company issuing the security. This report is issued in Spain by Santander Central Hispano Bolsa, Sociedad de Valores, S.A. (SCH Bolsa), and in the United Kingdom by Banco Santander, S.A., London Branch (Santander London), which is regulated by the Financial Services Authority in the conduct of investment business in the UK. This report is not being issued to private customers. SIS, Santander London, and SCH Bolsa are members of Grupo Santander. The following analysts hereby certify that their views about the companies and their securities discussed in this report are accurately expressed, that their recommendations reflect solely and exclusively their personal opinions, and that such opinions were prepared in an independent and autonomous manner, including as regards the institution to which they are linked, and that they have not received and will not receive direct or indirect compensation in exchange for expressing specific recommendations or views in this report, since their compensation and the compensation system applying to Grupo Santander and any of its affiliates is not pegged to the pricing of any of the securities issued by the companies evaluated in the report, or to the income arising from the businesses and financial transactions carried out by Grupo Santander and any of its affiliates: Gonzalo Fernandez. Grupo Santander receives non-investment banking revenue from the subject companies, with the exception of Homex, Sare, Geo. Within the past 12 months, Grupo Santander has managed or co-managed a public offering of securities of Ara, Sare. Within the past 12 months, Grupo Santander has received compensation for investment banking services from Sare. In the next three months, Grupo Santander expects to receive or intends to seek compensation for investment banking services from Ara, Geo. The information contained herein has been compiled from sources believed to be reliable, but, although all reasonable care has been taken to ensure that the information contained herein is not untrue or misleading, we make no representation that it is accurate or complete and it should not be relied upon as such. All opinions and estimates included herein constitute our judgment as at the date of this report and are subject to change without notice. Any U.S. recipient of this report (other than a registered broker-dealer or a bank acting in a broker-dealer capacity) that would like to effect any transaction in any security discussed herein should contact and place orders in the United States with SIS, which, without in any way limiting the foregoing, accepts responsibility (solely for purposes of and within the meaning of Rule 15a-6 under the U.S. Securities Exchange Act of 1934) for this report and its dissemination in the United States by Santander Investment Securities Inc. All Rights Reserved. 2007

CEMEX Cemex Increases its Offer for Rinker by 22%

CEMEX Cemex Increases its Offer for Rinker by 22% Latin American Equity Research Mexico City, April 10, 2007 Flashnote Mexico Cement & Construction CEMEX Cemex Increases its Offer for Rinker by 22% Gonzalo Fernandez* BUY Vivian Salomón* Mexico: Banco

More information

Latin American Equity Research. Mr. F. Chico to Tender for 42.65% of Asur Shares at M$56.00

Latin American Equity Research. Mr. F. Chico to Tender for 42.65% of Asur Shares at M$56.00 Latin American Equity Research Mexico City, March 30, 2007 Flashnote Mexico Airports ASUR Mr. F. Chico to Tender for 42.65% of Asur Shares at M$56.00 BUY Gonzalo Fernández* Vivian Salomón* Mexico: Banco

More information

MEXICAN AIRPORTS EARNINGS PREVIEW

MEXICAN AIRPORTS EARNINGS PREVIEW Latin American Equity Research Mexico City, April 20, 2009 Sector Preview Mexico Aerospace & Transportation MEXICAN AIRPORTS EARNINGS PREVIEW A Tough 1Q09, Driven by Weak Passenger Figures Luis Miranda,

More information

KIMBERLY CLARK DE MEXICO Re-Rating Completed; Downgrading to Hold

KIMBERLY CLARK DE MEXICO Re-Rating Completed; Downgrading to Hold Latin American Equity Research Mexico City, November 20, 2006 KIMBERLY CLARK DE MEXICO Re-Rating Completed; Downgrading to Hold Joaquín Ley* Mexico: Santander Banco Santander S.A. 5255) 5269-1921 jley@santander.com.mx

More information

Latin American Equity Research. Alfa Agrees to Sell Hylsamex and Sidor Stakes to Techint

Latin American Equity Research. Alfa Agrees to Sell Hylsamex and Sidor Stakes to Techint Latin American Equity Research Mexico, May 19, 2005 ALFA Flashnote Mexico Conglomerates STRONG BUY Alfa Agrees to Sell Hylsamex and Sidor Stakes to Techint Luis Miranda, CFA (5255) 5269-1926 lmiranda@santander.com.mx

More information

1Q05 Results Were Strong Overall and Better than Expected; Some Flags in Sigma

1Q05 Results Were Strong Overall and Better than Expected; Some Flags in Sigma Latin American Equity Research Mexico, April 21, 2005. Earnings Comment Mexico Conglomerates ALFA (US$4.71) (ALFAA) STRONG BUY TARGET PRICE: US$6.15 1Q05 Results Were Strong Overall and Better than Expected;

More information

CEMEX (US$24.03) Positive 3Q03 Operating Results and Advances on the Financial Front TARGET PRICE: US$27.00

CEMEX (US$24.03) Positive 3Q03 Operating Results and Advances on the Financial Front TARGET PRICE: US$27.00 Latin America Quarterly Earnings Report CEMEX (US$24.03) (CX) Mexico Cement & Construction Mexico City, October 9, 2003 U.S. investors inquiries should be directed to Santander Central Hispano Investment

More information

WALMEX HOLD. Have You Looked at P/BV? (12/14/05) CURRENT PRICE: US$5.81/M$62.35 TARGET PRICE: US$5.70/M$65.00

WALMEX HOLD. Have You Looked at P/BV? (12/14/05) CURRENT PRICE: US$5.81/M$62.35 TARGET PRICE: US$5.70/M$65.00 Latin American Equity Research Mexico City, December 15, 2005 WALMEX Have You Looked at P/BV? Company Report Mexico Retail HOLD Joaquin Ley* Daniela M. Bretthauer* Mexico: Banco Santander Serfin, S.A Brazil:

More information

MEXICO TMT SECTOR JANUARY 2011

MEXICO TMT SECTOR JANUARY 2011 Latin American Equity Research Mexico City, January 31, 2011 Sector Preview Mexico Telecom, Media & Technology MEXICO TMT SECTOR JANUARY 2011 Post-Cancun Update and 4Q10 Previews Gregorio Tomassi*, CFA

More information

ICA BUY. ICA Reloaded: Setting 2004 Target, Upgrading to Buy (12/23/03) CURRENT PRICE: US$1.41/M$2.58 TARGET PRICE: US$1.75/M$3.30

ICA BUY. ICA Reloaded: Setting 2004 Target, Upgrading to Buy (12/23/03) CURRENT PRICE: US$1.41/M$2.58 TARGET PRICE: US$1.75/M$3.30 Latin American Equity Research ICA Mexico Cement & Construction Mexico City, December 26, 2003 ICA Reloaded: Setting 2004 Target, Upgrading to Buy Gonzalo Fernández (5255) 5269-1931 gofernandez@santander.com.mx

More information

Latin American Equity Research

Latin American Equity Research Latin American Equity Research New York, July 13, 2009 Sector Report Latam Mining MIND THE GAP Worst Case Has Limited Downside Potential GMEXICO VS. PCU Luis Miranda*, CFA Victoria Santaella Alonso Aramburu

More information

GRUPO AEROPORTUARIO DEL PACIFICO HOLD. Reaches Cruising Altitude; Downgrading to Hold

GRUPO AEROPORTUARIO DEL PACIFICO HOLD. Reaches Cruising Altitude; Downgrading to Hold Latin American Equity Research Mexico City, December 1, 2006 Company Report Mexico Airports GRUPO AEROPORTUARIO DEL PACIFICO Reaches Cruising Altitude; Downgrading to Hold Gonzalo Fernandez* HOLD Vivian

More information

Growth Opportunities Remain Intact, Introducing YE2011 Target Price

Growth Opportunities Remain Intact, Introducing YE2011 Target Price Latin American Equity Research Mexico City, August 2, 2010 Company Report Mexico Healthcare GENOMMA LAB Growth Opportunities Remain Intact, Introducing YE2011 Target Price Joaquin Ley* BUY Daniel Gewehr*

More information

(5255) (5255)

(5255) (5255) Latin American Equity Research Mexico City, February 24, 2009 WALMEX For Those About to Buy, We Salute You Upgrading to Buy Joaquin Ley* Company Update Mexico Retail BUY Roberto Liaño* Mexico: Banco Santander

More information

CSCK 12. Credit Suisse Mexico Credit Opportunities Trust January Overview. Investment Performance

CSCK 12. Credit Suisse Mexico Credit Opportunities Trust January Overview. Investment Performance CSCK 12 Credit Suisse Mexico Credit Opportunities Trust January 2019 This document is for information purposes only. The information contained herein is public, comes from public sources or is informative

More information

ECONOMICS July 18, 2016 BRAZIL Credit Market

ECONOMICS July 18, 2016 BRAZIL Credit Market Dec-3 Jan-2 Aug-2 Mar-3 Oct-3 May- Jul- Feb-6 Sep-6 Apr-7 Nov-7 Jan-9 Aug-9 Mar- Oct- May-11 Jul-12 Feb-13 Sep-13 Apr-1 Nov-1 Jan-16 ECONOMICS July 18, 16 BRAZIL Credit Market What Can Credit Do for Brazilian

More information

3,951 EBITDA 1,174 1,153 1,260 1,284 1,332 Outst shares (mn) 57 EBIT Free float (%)

3,951 EBITDA 1,174 1,153 1,260 1,284 1,332 Outst shares (mn) 57 EBIT Free float (%) European Equity Research ACCIONA Facing a Good 2017E Spain Electricity November 7, 2016 (07:15 CET) BUY CURRENT PRICE: 69.01 TARGET PRICE: 82.40 ANA released 9M16 results on Nov 4 and we have adjusted

More information

Asset Allocation Guide

Asset Allocation Guide JULY 2014 RBC WEALTH MANAGEMENT GLOBAL INSIGHT PERSPECTIVES FROM THE GLOBAL PORTFOLIO ADVISORY COMMITTEE Asset Allocation Guide In conjunction with the Global Insight publications, following is an updated

More information

ECONOMICS March 20, 2017 Brazil: Exchange Rate

ECONOMICS March 20, 2017 Brazil: Exchange Rate ECONOMICS March 20, 2017 Brazil: Exchange Rate Monetary Easing: The BRL Is the Limit Maurício Molan* mmolan@santander.com.br +55 11 3012-5724 We believe that Brazil is well positioned to enter a new era

More information

CEMEX Cement. Quarterly Report July 27, CX: Proving the success of its Value-before-Volume strategy.

CEMEX Cement. Quarterly Report July 27, CX: Proving the success of its Value-before-Volume strategy. Quarterly Report CEMEX Market Outperformer 12M FWD Price Target US$10.8 Price 7.1 12M Price Range 3.8/8.6 Shares Outstanding (Mill)* 1,542 Market Cap USD (Mill) 10,976 Float 78.6% Net Debt USD (Mill)**

More information

FX and Capital Markets

FX and Capital Markets FX and Capital Markets Highlights of the Week November, 1 Domestic and international drivers pressure the BRL Brazilian currency underperformed its peers last week Improved data on the U.S. economy released

More information

ECONOMICS CHILE. Inside Latin America 4Q08: 2009, Surviving the Storm

ECONOMICS CHILE. Inside Latin America 4Q08: 2009, Surviving the Storm ECONOMICS Economics Research Ernest W. (Chip) Brown, Head 212-583-4663 ebrown@santander.us CHILE October 21, 28 Inside Latin America 4Q8: 29, Surviving the Storm Pablo Correa, Juan Pablo Castro 562-336-3361

More information

CEMEX Cement. Quarterly Report February 9, CEMEX remains on track to regain its investment grade.

CEMEX Cement. Quarterly Report February 9, CEMEX remains on track to regain its investment grade. Quarterly Report CEMEX Market Outperformer 2017 Price Target US$11.0 Price 8.9 12M Price Range 4.1/9.5 Shares Outstanding (Mill)* 1,545 Market Cap USD (Mill) 13,797 Float 78.6% Net Debt USD (Mill)** 12,516

More information

ECONOMICS August 28, 2018 Brazil FX

ECONOMICS August 28, 2018 Brazil FX ECONOMICS August 28, 218 Brazil FX We re Not in 22 Anymore (Caution Advised, Though) Maurício Molan* and Luciano Sobral* lusobral@santander.com.br 11-33-373 Perceptions of Brazil s public sector solvency

More information

Grupo Sura. Equity Research. 4Q14: FX distorts a continuation of good operating trends

Grupo Sura. Equity Research. 4Q14: FX distorts a continuation of good operating trends Equity Research Grupo Sura 4Q14: FX distorts a continuation of good operating trends Operating lines beat us (again), but FX losses hit bottom line (as expected) Sura s 4Q14 insurance and asset management

More information

More Growth Ahead at an Attractive Valuation: Raising Target Price

More Growth Ahead at an Attractive Valuation: Raising Target Price Latin American Equity Research New York, November 22, 2010 Company Report Mexico Mining GRUPO MEXICO More Growth Ahead at an Attractive Valuation: Raising Target Price Victoria Santaella BUY Sergio Matsumoto

More information

GENOMMA LAB BUY. A Prescription for Growth; Increasing YE2010 Target Price (9/28/09) CURRENT PRICE: M$17.46/US$1.29 TARGET PRICE: M$30.00/US$2.

GENOMMA LAB BUY. A Prescription for Growth; Increasing YE2010 Target Price (9/28/09) CURRENT PRICE: M$17.46/US$1.29 TARGET PRICE: M$30.00/US$2. Latin American Equity Research Mexico City, October 1, 2009 Company Update Mexico Health Care GENOMMA LAB A Prescription for Growth; Increasing YE2010 Target Price BUY Joaquin Ley* Daniel Gewehr* Roberto

More information

Still Robust Top-Line Growth to Offset Infrastructural Build-Out. Alexander Robarts Joaquin Ley* Alonso Aramburu

Still Robust Top-Line Growth to Offset Infrastructural Build-Out. Alexander Robarts Joaquin Ley* Alonso Aramburu Latin American Equity Research New York, July 11, 2006 Company Report Mexico Food GRUMA Still Robust Top-Line Growth to Offset Infrastructural Build-Out BUY Alexander Robarts Joaquin Ley* Alonso Aramburu

More information

Acquisitions Appear Priced In; Downgrading on Valuation vs. Global Peers (212) (212)

Acquisitions Appear Priced In; Downgrading on Valuation vs. Global Peers (212) (212) Latin American Equity Research New York, June 9, 2008 COCA-COLA FEMSA Company Update Mexico Beverages UNDERPERFORM Acquisitions Appear Priced In; Downgrading on Valuation vs. Global Peers Alexander Robarts

More information

View from the market Jahangir Aziz

View from the market Jahangir Aziz S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L View from the market Jahangir Aziz 202-585-1254 jahangir.x.aziz@jpmorgan.com Mar-09 Aug-09 Dec-09 May-10 Oct-10 Mar-11 Aug-11 Jan-12 INR: India

More information

CEMEX HOLD (2/17/09) CURRENT PRICE: US$7.05/M$10.50 TARGET PRICE: US$8.00/M$11.00

CEMEX HOLD (2/17/09) CURRENT PRICE: US$7.05/M$10.50 TARGET PRICE: US$8.00/M$11.00 Latin American Equity Research Mexico City, February 17, 2009 CEMEX Company Report Mexico Cement & Construction The Long and Winding Road Lowering Target and Reiterating Hold Gonzalo Fernández* Mexico:

More information

GFINBUR Banks. Quarterly Report July 28, GFINBUR: Strong operating results hidden by non-cash losses.

GFINBUR Banks. Quarterly Report July 28, GFINBUR: Strong operating results hidden by non-cash losses. Quarterly Report GFINBURSA Market Outperformer 2016e Price Target P$39.0 Price 31.16 12M Price Range 27.82 / 42.48 Shares Outstanding (Mill) 6,667 Market Cap (Mill) 207,745 Float 33.6% Deposits (Mill)

More information

P/BV 12M PRICE PERFORMANCE VS. IPC P/E FWD

P/BV 12M PRICE PERFORMANCE VS. IPC P/E FWD Quarterly Report FINDEP Market Performer 12M FWD Price Target P$3.5 Price 3.85 12M Price Range 2.70 / 5.18 Shares Outstanding (Mill) 715.9 Market Cap (Mill) 2756.2 Float 36.6% Total Debt (Mill) 6,562 Stockholder

More information

Brazil: FX and Capital Markets Highlights of the Week

Brazil: FX and Capital Markets Highlights of the Week Brazil: FX and Capital Markets Highlights of the Week Monday, May 11, 1 International Market Reopens for Brazilian Issuances Brazilian currency appreciated again last week. Notwithstanding some depreciation

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report November 8, 2018 Viking Therapeutics (VKTX - $13.74) 3Q18: Conference Call Uneventful with Investor Focus on the Design

More information

Brazil: FX and Capital Markets Highlights of the Week

Brazil: FX and Capital Markets Highlights of the Week Brazil: FX and Capital Markets Highlights of the Week Monday, April 7, 1 Currency flow remains positive Brazilian currency maintained the good performance of the previous weeks. The real kept last week

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report November 7, 2018 Alimera Sciences (ALIM - $1.09) Quarter Mostly in-line, 2019 could Benefit from Repeat Usage ALIM

More information

FX and Capital Markets

FX and Capital Markets FX and Capital Markets Highlights of the Week May, 7 BRL outperforms peer currencies during the week BRL remains virtually stable in a week of emerging market currencies depreciation Falling commodity

More information

4Q16. Financial Results as of December 31, 2016 GBOOY. Contact: +52 (55)

4Q16. Financial Results as of December 31, 2016 GBOOY. Contact:  +52 (55) 4Q16 Financial Results as of December 31, 2016 Contact: investor@banorte.com www.banorte.com/ri +52 (55) 1670 2256 GFNORTE GBOOY XNOR Table of Content I. Summary... 3 II. Management s Discussion & Analysis...

More information

FX and Capital Markets

FX and Capital Markets FX and Capital Markets Highlights of the Week June, 7 Weaker U.S. labor market boosts the BRL Brazilian currency rebounds Weaker figures on the U.S. labor market undermined the dollar against many currencies,

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.07) Impressive Ex-US Sales Help ALIM Exceed Topline Expectations. ALIM recently announced

More information

GCC REPORTS FIRST QUARTER 2018 RESULTS

GCC REPORTS FIRST QUARTER 2018 RESULTS GCC REPORTS FIRST QUARTER 2018 RESULTS Chihuahua, Chihuahua, Mexico, April 24, 2018 Grupo Cementos de Chihuahua, S.A.B. de C.V. (BMV: GCC *), a leading producer of cement and ready-mix concrete in the

More information

CVC. Equity Research. Another solid sales showing. Latin America Retailing Company Note 07 April 2015

CVC. Equity Research. Another solid sales showing. Latin America Retailing Company Note 07 April 2015 Equity Research CVC Another solid sales showing Promotional environment drove sales in Q1 Bookings rose 11% y/y to R$1.269bn, supported by 6.4% SSS and the opening of 105 stores (totaling 919 exclusive

More information

2Q16 Highlights: 12M FWD EV/EBITDA 12M PRICE PERFORMANCE VS. IPC P/E

2Q16 Highlights: 12M FWD EV/EBITDA 12M PRICE PERFORMANCE VS. IPC P/E GISSA Market Outperformer 12M FWD Price Target P$45.0 Price 31.4 12M Price Range 29.5/ 33.09 Shares Outstanding 356 Market Cap (Mill) 11,169 Float 19.5% Net Debt (Mill) 46 EV (Mill) 11,164 Dividend Yield

More information

Important information

Important information 26 April 2012 1 Important information 2 Banco Santander, S.A. ("Santander") cautions that this presentation contains forward-looking statements. These forward-looking statements are found in various places

More information

DKK: foreign investors bought government bonds and treasury bills in August

DKK: foreign investors bought government bonds and treasury bills in August DKK: foreign investors bought government bonds and treasury bills in August Jens Nærvig Pedersen Analyst Danske Bank Markets jenpe@danskebank.dk +45 45 12 8 61 27 September 213 Important disclosures and

More information

Daily volume Rodobens. Company. Company. (US$mn) Avg 30d CCDI General Shopping Agra 13.2

Daily volume Rodobens. Company. Company. (US$mn) Avg 30d CCDI General Shopping Agra 13.2 Research Team Latam Real Estate Valuation update LATAM EQUITY RESEARCH Sector update Prices as of 22 May 2009 Marcelo Telles, CFA 55 11 3841.6338 marcelo.telles@credit-suisse.com Rodrigo Oliveira 55 11

More information

VIX to Fall; Stocks to Rise; Small to Outperform

VIX to Fall; Stocks to Rise; Small to Outperform RBC Capital Markets, LLC October 14, 2014 VIX to Fall; Stocks to Rise; Small to Outperform Market Delivers Above-Average Returns Following Volatility Spikes Investor concerns regarding global growth have

More information

Asia Equity Strategy Research Analysts Sakthi Siva

Asia Equity Strategy Research Analysts Sakthi Siva Asia Pacific Equity Research Investment Strategy Asia Equity Strategy Research Analysts Sakthi Siva 65 6212 3027 sakthi.siva@credit-suisse.com Kin Nang Chik 852 2101 7482 kinnang.chik@credit-suisse.com

More information

BBVA Bancomer. Focused on continuing growth

BBVA Bancomer. Focused on continuing growth BBVA Bancomer Focused on continuing growth 1 Disclaimer This document is only provided for information purposes and does not constitute, nor must it be interpreted as, an offer to sell or exchange or acquire,

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.80) Iluvien sales continue their slow & steady growth ALIM reported 1Q16 roughly in-line

More information

Allscripts Healthcare Solutions, Inc.

Allscripts Healthcare Solutions, Inc. HEALTHCARE: Healthcare Technology Company Update / Estimates Change Allscripts Healthcare Solutions, Inc. MDRX: Continuing the String of Bookings We reiterate our SW rating on Allscripts (MDRX) due to

More information

Macro Vision June 13, 2017

Macro Vision June 13, 2017 Macro Vision June 13, 2017 Country risk: how far can it reach? The global environment has been favorable to emerging markets, despite the recent drop in commodity prices. Better global growth and lower

More information

Investor Presentation. London - March, 2016

Investor Presentation. London - March, 2016 Investor Presentation London - March, 2016 Disclaimer Grupo Aval Acciones y Valores S.A. ( Grupo Aval ) is an issuer of securities in Colombia and the United States, registered with Colombia s National

More information

Darden Restaurants, Inc.

Darden Restaurants, Inc. Darden Restaurants, Inc. DRI: Reports Solid Performance; Expectations Were Pretty High Despite Evidence Segment Is Slowing Our View: We reiterate our OW rating following shares coming under pressure because

More information

China Renewable Energy Investment Ltd (987_HK)

China Renewable Energy Investment Ltd (987_HK) Wednesday, March 21, 2018 www.evaluateresearch.com Target Price HK$ 0.50 Current Price HK$ 0.23 Upside Potential 117% Market Cap. Shares Outstanding HK$ 525 mn $ 66.90 mn 2,364.7 mn Free Float (FF %) 631.9

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Cytori Therapeutics (CYTX - $ 2.32) BARDA Decision is a Major Positive Development Yesterday, CYTX

More information

[Please refer to Appendix. Regions Financial Corp. (RF) Q3 Initial Thoughts: Mixed Quarter with Lower Provisioning but Weaker NII RESEARCH UPDATE

[Please refer to Appendix. Regions Financial Corp. (RF) Q3 Initial Thoughts: Mixed Quarter with Lower Provisioning but Weaker NII RESEARCH UPDATE October 18, 2016 Baird Equity Research US Banks Regions Financial Corp. (RF) Q3 Initial Thoughts: Mixed Quarter with Lower Provisioning but Weaker NII RF reported Q316 EPS of $0.24 (vs. Baird $0.22). Non-core

More information

Qualicorp. Equity Research. Bahia state court ruling suspends price hike for SULA plans

Qualicorp. Equity Research. Bahia state court ruling suspends price hike for SULA plans Equity Research BTG Pactual Affiliate Research Banco BTG Pactual S.A. Latin America Health Care SectorNote 04 July 2016 Bahia state court ruling suspends price hike for SULA plans Negative news, but with

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Mast Therapeutics (MSTX - $ 0.49) Patient Recruitment for Vepoloxamer Pivotal (EPIC) Trial is On-track

More information

FLASH NOTE EQUITY RESEARCH. OUTPERFORM Price target 6.40 Price Elanix Biotechnologies AG (ELN-DE) Updates from webcast include financial outlook

FLASH NOTE EQUITY RESEARCH. OUTPERFORM Price target 6.40 Price Elanix Biotechnologies AG (ELN-DE) Updates from webcast include financial outlook ELANIX BIOTECHNOLOGIES AG Biotechnology 8 August 2018 09:54 BST FLASH NOTE Elanix Biotechnologies AG (ELN-DE) Updates from webcast include financial outlook OUTPERFORM Price target 6.40 Price 2.72 KEY

More information

Room for tighter asset swap spreads as issuance picks up

Room for tighter asset swap spreads as issuance picks up Room for tighter asset swap spreads as issuance picks up Senior Analyst Senior Analyst Peter Possing Andersen Lars Tranberg Rasmussen +45 4513 719 + 45 4512 8534 pa@danskebank.dk laras@danskebank.dk Trade

More information

Macro Vision February 20, 2017

Macro Vision February 20, 2017 Macro Vision February 20, 2017 Finding MXN equilibrium in more challenging conditions Traditional exchange rate models indicate that the Mexican peso is undervalued. When presenting the results, we are

More information

Aveda Transportation and Energy Services Inc. (AVE-V)

Aveda Transportation and Energy Services Inc. (AVE-V) Aveda Transportation and Energy Services Inc. (AVE-V) Strong Q3 Results Driven by Impressive US Growth November 5, 2013 Michael Mills, CFA (902) 425-8897 mmills@beaconsecurities.ca Aveda reported inline

More information

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016 EQUITY RESEARCH QUARTERLY UPDATE September 22, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $900.00 AZO - NYSE $751.45 3-5 Yr. EPS Gr. Rate 14% 52-Wk Range $819.54-$681.01 Shares Outstanding 30.8M

More information

Brazilian Payment Industry

Brazilian Payment Industry Equity Research Brazilian Payment Industry Latin America Financial, Diversified SectorNote 12 June 215 CB wants more competition, but regulatory powers to be used only when really needed Surveillance report

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Mast Therapeutics (MSTX - $ 0.56) Rivipansel (GMI-1070) in Resolving Vaso-occlusive Crisis (VOC) of

More information

VITRO Conglomerates. Quarterly Report July 29, VITRO Market Outperformer 12M FWD Price Target P$73.0

VITRO Conglomerates. Quarterly Report July 29, VITRO Market Outperformer 12M FWD Price Target P$73.0 Quarterly Report VITRO Market Outperformer 12M FWD Price Target P$73.0 Price 61.1 12M Price Range 36.3/ 66.7 Shares Outstanding (Mill) 483.6 Market Cap (Mill) 1,564 Float 20% Net Debt ( Mill) -424 EV Adj.

More information

HSBC Bank Oman SAOG. TP : OMR / share Upside/ (Downside): 19.7% HSBC Bank Oman SAOG. Page 1 of 7

HSBC Bank Oman SAOG. TP : OMR / share Upside/ (Downside): 19.7% HSBC Bank Oman SAOG. Page 1 of 7 Recommendation Accumulate Bloomberg Ticker HBMO OM Current Market Price (OMR).117 52wk High / Low (OMR).13/. 12m Average Vol. () 386.2 Mkt. Cap. (USD/OMR Mn) 68/234 Shares Outstanding (mn) 2,.3 Free Float

More information

Why Investors Might Want to Hedge the Euro

Why Investors Might Want to Hedge the Euro WisdomTree Research MARKET INSIGHTS [ August 2012 ] Why Investors Might Want to Hedge the Euro BY JEREMY SCHWARTZ, CFA, DIRECTOR OF RESEARCH, & CHRISTOPHER JABARA, RESEARCH ANALYST To resolve its debt

More information

Chile. 3Q09 Results. Boadilla, October 2009

Chile. 3Q09 Results. Boadilla, October 2009 3Q09 Results Boadilla, October 2009 Important Information 2 Banco Santander, S.A. ("Santander") cautions that this presentation contains forward-looking statements within the meaning of the US Private

More information

Shenhua Reuters: 1088.HK, Bloomberg: 1088 HK; YCM Reuters: 1171.HK, Bloomberg: 1171 HK

Shenhua Reuters: 1088.HK, Bloomberg: 1088 HK; YCM Reuters: 1171.HK, Bloomberg: 1171 HK 20 December 20 China Coal Market Decelerating production growth Firm spot coal prices expected in 2006: China s coal production in November only grew by 3.1% Y/Y, highlighting the production disruption

More information

Earnings Results. Second Quarter 2015

Earnings Results. Second Quarter 2015 Earnings Results Second Quarter 2015 Forward Looking Statements This presentation contains, or may be deemed to contain, forward-looking statements. By their nature, forward-looking statements involve

More information

HSBC World Selection Portfolio Quarterly Report Q4 2018

HSBC World Selection Portfolio Quarterly Report Q4 2018 HSBC World Selection Portfolio Quarterly Report Q4 2018 Date: January 2019 This commentary provides a high-level overview of the recent economic environment and is for information purposes only. It is

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Emergent BioSolutions (EBS - $34.89) Another Acquisition in EBS s Wheelhouse, 2020 Topline $1B Goal in Sight Yesterday

More information

Coca Cola FEMSA (KOF)

Coca Cola FEMSA (KOF) Mexico and Brazil posted good results, and fully offset the decreases in Central America and Venezuela. Mexico has not slowed down its growth rate. Both prices and volumes performed positively. Brazil

More information

DKK: Unchanged appetite for Danish bonds among foreign investors in September

DKK: Unchanged appetite for Danish bonds among foreign investors in September DKK: Unchanged appetite for Danish bonds among foreign investors in September Jens Nærvig Pedersen Analyst Danske Bank Markets jenpe@danskebank.dk +45 45 12 8 61 28 October 213 Important disclosures and

More information

Analyst's Notes. Argus Recommendations

Analyst's Notes. Argus Recommendations Report created Jan 17, 2018 Page 1 OF 5 Citigroup is one of world's largest banks, with global consumer banking, corporate banking, and investment banking operations. Of the largest U.S. banks, Citigroup

More information

Page 1 of 8. Transaction Profile. Transaction Key Features. Supporting Ratings. Publication Date: April 20, 2004 RMBS Presale Report

Page 1 of 8. Transaction Profile. Transaction Key Features. Supporting Ratings. Publication Date: April 20, 2004 RMBS Presale Report Publication Date: April 20, 2004 RMBS Presale Report Fondo de Titulización Hipotecaria UCI 10 700 million mortgage-backed floating-rate notes Analysts: Jerome Cretegny, London (44) 20-7176-3614, José Ramón

More information

Embraer. Equity Research. Order from Japan Airlines. Latin America Capital Goods Company Note 28 August 2014

Embraer. Equity Research. Order from Japan Airlines. Latin America Capital Goods Company Note 28 August 2014 Equity Research Order from Japan Airlines New order from Japan Airlines; potential split with Mitsubishi Japan Airlines (JAL) has signed a firm order with ERJ for 15 E-Jets (E170 and E190 models) totaling

More information

LoopNet. $28 $26 $24 $22 $20 $18 $16 $14 $12 $10 Jun-06 Sep-06 Dec-06 Mar-07 Jun-07

LoopNet. $28 $26 $24 $22 $20 $18 $16 $14 $12 $10 Jun-06 Sep-06 Dec-06 Mar-07 Jun-07 July 31, 2007 Analyst Highlights Street Estimates Recommendation: BUY 2006A 2007E 2008E Current Price: $21.01 EPS $0.40 $0.48 $0.59 Target Price: $25.00 P/E 52.5 43.8 35.6 Forecast Stock Return: 19.0%

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Mast Therapeutics (MSTX - $ 0.61) 2Q14: EPIC Study On-track and More Details of Other Pipeline Developments

More information

[Please refer to Appendix. Wells Fargo & Company (WFC) Q2 Initial Thoughts: Revenue Trends Modestly Below Expectations RESEARCH UPDATE

[Please refer to Appendix. Wells Fargo & Company (WFC) Q2 Initial Thoughts: Revenue Trends Modestly Below Expectations RESEARCH UPDATE July 15, 2016 Baird Equity Research US Banks Wells Fargo & Company (WFC) Q2 Initial Thoughts: Revenue Trends Modestly Below Expectations WFC reported Q216 EPS of $1.01 (Baird $1.02, consensus $1.01). Non-core

More information

Marisa. Equity Research. Poor retail showing despite easy comps; new CFO unveiled. Latin America Retailing Company Note 07 November 2014

Marisa. Equity Research. Poor retail showing despite easy comps; new CFO unveiled. Latin America Retailing Company Note 07 November 2014 Equity Research Marisa Poor retail showing despite easy comps; new CFO unveiled Disappointing top line growth still impacted by the World Cup Marisa posted an SSS decline of 1.5% (vs. 's -7.5%) as: (i)

More information

Charting the Course. Can MXAPJ Sustain Jan Rally? Rotational Opportunities Best; Asia Technicals Strategy

Charting the Course. Can MXAPJ Sustain Jan Rally? Rotational Opportunities Best; Asia Technicals Strategy Charting the Course Can MXAPJ Sustain Jan Rally? Rotational Opportunities Best; Asia Technicals Strategy Priced on 01 Feb 2012 Asia Technical Analysis Research AC J.P. Morgan Securities (Asia Pacific)

More information

of last year. United States.

of last year. United States. For more information: inversionistas@gcc.com GCC REPORTS FIRST QUARTER 2012 RESULTS Chihuahua, Chih., Mexico, May 2nd, 2012 Grupo Cementos de Chihuahua, S.A.B. de C.V. ( GCC or the Company ) (BMV: GCC*),

More information

Notes Linked to the S&P Economic Cycle Factor Rotator Index due April 30, 2025

Notes Linked to the S&P Economic Cycle Factor Rotator Index due April 30, 2025 The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities

More information

LifeVantage Corp. NasdaqCM: LFVN

LifeVantage Corp. NasdaqCM: LFVN LifeVantage Corp. NasdaqCM: LFVN New Products and Valuation Outweigh issues in Japan, reiterate Strong Buy LifeVantage Corp (LFVN) focuses on selling healthy living products through direct selling. They

More information

Chile. 2Q09 Results. Boadilla, July 2009

Chile. 2Q09 Results. Boadilla, July 2009 2Q09 Results Boadilla, July 2009 Important Information 2 Banco Santander, S.A. ("Santander") cautions that this presentation contains forward-looking statements within the meaning of the US Private Securities

More information

Dollarama Inc. Q2 F2017 Preview. (1) Growth expected to continue (2) A deeper look at valuation HIGHLIGHTS. The NBF Daily Bulletin.

Dollarama Inc. Q2 F2017 Preview. (1) Growth expected to continue (2) A deeper look at valuation HIGHLIGHTS. The NBF Daily Bulletin. DOL (T) $97.04 Stock Rating: Outperform (Unchanged) Target: $105.00 (Was $104.00) Risk Rating: Average (Unchanged) Est. Total Return: 8.6% Stock Data: 52-week High-Low (Canada) Bloomberg $98.94 - $66.32

More information

Davivienda. Equity Research. Investment Gains Drove Strong 3Q. Colombia Banks (Exclu. Savings & Loan) Company Note 18 November 2013

Davivienda. Equity Research. Investment Gains Drove Strong 3Q. Colombia Banks (Exclu. Savings & Loan) Company Note 18 November 2013 Equity Research Davivienda Investment Gains Drove Strong 3Q Net income jumped 92% y/y; ROE of 22.3% in 3Q Davivienda s net income almost doubled y/y in 3Q, beating our estimates by 17%, thanks mainly to

More information

Templeton Latin America Fund A (Ydis) USD

Templeton Latin America Fund A (Ydis) USD Templeton Latin America Fund A (Ydis) USD Franklin Templeton Investment Funds Fund Manager Report Value Equity Product Details 1 Fund Assets $969558829.19 Fund Inception Date 28/02/1991 Number of Issuers

More information

Brazil Economic Outlook for 2013

Brazil Economic Outlook for 2013 Emerging Markets Research January 13 Brazil Economic Outlook for 13 Luis Oganes Head of Latin America Research Growth-inflation dilemma: Brazil s growth expected to remain below potential through 1Q13

More information

GCC REPORTS FOURTH QUARTER 2012 RESULTS

GCC REPORTS FOURTH QUARTER 2012 RESULTS For more information: inversionistas@gcc.com GCC REPORTS FOURTH QUARTER 2012 RESULTS Chihuahua, Chih., Mexico, February 25, 2013 Grupo Cementos de Chihuahua, S.A.B. de C.V. ( GCC or the Company ) (BMV:

More information

Copel. Equity Research. Big boost from Araucária. Latin America Electric & Other Utilities Company Note 15 May 2015

Copel. Equity Research. Big boost from Araucária. Latin America Electric & Other Utilities Company Note 15 May 2015 Equity Research Big boost from Araucária Strong quarter reported much stronger-than-expected figures. Similar to most of the companies that reported, part of the outperformance comes from an energy allocation

More information

[Please refer to Appendix. Sherwin-Williams Co. (SHW) High-Quality Beat Positive for Shares RESEARCH UPDATE

[Please refer to Appendix. Sherwin-Williams Co. (SHW) High-Quality Beat Positive for Shares RESEARCH UPDATE April 21, 2016 Baird Equity Research Packaging & Coatings Sherwin-Williams Co. (SHW) High-Quality Beat Positive for Shares Strong start to 2016 led by core sales. We believe that the shares of Sherwin-Williams

More information

HSBC USA Inc. Autocallable Yield Notes

HSBC USA Inc. Autocallable Yield Notes Filed Pursuant to Rule 433 Registration No. 333-202524 FREE WRITING PROSPECTUS Dated August 1, 2016 (To Prospectus dated March 5, 2015, Prospectus Supplement dated March 5, 2015 and Equity Index Underlying

More information

Fourth Quarter 2014 Consolidated Results Conference Call

Fourth Quarter 2014 Consolidated Results Conference Call Fourth Quarter 2014 Consolidated Results Conference Call April 14, 2015 Investor Relations 2 Disclaimer Banco de Bogotá and its respective Colombian financial subsidiaries, including Porvenir and Corficolombiana,

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report June 1, 2018 Viking Therapeutics (VKTX - $9.99) Outlook of VK2809 in NAFLD Continues to Improve; Increase Our Target

More information

GS Global ECS Credit Strategy Research. March 31, Alberto Gallo, CFA Goldman, Sachs & Co

GS Global ECS Credit Strategy Research. March 31, Alberto Gallo, CFA Goldman, Sachs & Co The Goldman Sachs Group, Inc. Goldman Sachs Research The CLO market shows signs of life GS Global ECS Credit Strategy Research March 31, 11 Alberto Gallo, CFA Goldman, Sachs & Co. 1-917-33-31 alberto.gallo@gs.com

More information